
Click on, or paste the following link into your web browser, to view the associated PDF document:
http://www.rns-pdf.londonstockexchange.com/rns/5950X_1-2025-2-18.pdf
Commercial International Bank (Egypt) S.A.E. |
Consolidated Financial Statements - IFRS December 31, 2024
|
Consolidated Income Statement for the Year Ended December 31, 2024 |
| | | ||||
| |
|
|
|
| | |
| Notes | Dec. 31, 2024 |
| | Dec. 31, 2023 | | |
| |
|
| | | | |
| |
|
| | | | |
Interest and similar income | | 182,735,474 |
| | 104,028,379 | | |
Interest and similar expense |
| (91,751,450) | | | (51,142,688) | | |
Net interest income | 3 | 90,984,024 |
|
| 52,885,691 | | |
| |
|
| | | | |
Fee and commission income | | 12,813,876 |
| | 9,049,924 | | |
Fee and commission expense |
| (5,728,656) | | | (3,611,699) | | |
Net fee and commission income | 4 | 7,085,220 |
|
| 5,438,225 | | |
| |
|
| | | | |
Dividend income | 5 | 195,047 |
| | 234,010 | | |
Net trading income | 6 | 20,470,230 |
| | 4,006,880 | | |
Gain on investments | 20 | 459,337 |
| | 221,810 | | |
Intangible assets | | - |
| | (51,831) | | |
Goodwill | | - |
| | (206,287) | | |
Administrative expenses | 7 | (19,952,958) |
| | (13,299,910) | | |
Other operating expenses | 8 | (23,201,267) |
| | (6,341,869) | | |
Impairment charges for credit losses | 9 | (4,523,819) |
| | (4,270,081) | | |
Bank's share in the loss of associates | 12 | (17,786) | | | (55,983) | | |
Profit before income tax from continuing operations |
| 71,498,028 | | | 38,560,655 | | |
| |
|
| | | | |
Taxes | 10 | (21,878,946) |
| | (11,942,406) | | |
|
|
| | | | | |
Net profit from continued operations |
| 49,619,082 | | | 26,618,249 | | |
| |
|
| | | | |
Discontinued Operations |
|
|
| | | | |
Net (loss) from discontinued operations | 44 | - | | | (42,102) | | |
Net profit for the Year |
| 49,619,082 | | | 26,576,147 | | |
Attributable to: |
|
|
| | | | |
Equity holders of the parent | | 49,558,744 |
| | 26,541,824 | | |
Non-controlling interest |
| 60,338 |
|
| 34,323 | | |
Net Profit for the year |
| 49,619,082 |
|
| 26,576,147 | | |
| |
|
| | | | |
| |
|
| | | | |
| |
|
| | | | |
Earnings per share | 11 |
|
| | | | |
Basic attributable to equity holders of the parent | | 16.34 |
| | 8.75 | | |
Diluted attributable to equity holders of the parent | | 16.14 |
| | 8.64 | | |
| | | | | | | |
| | | | | | | |
The accompying notes from 1 to 44 form an integral part of these consolidated financial statements. |
| | | | | |
Consolidated Statement of Comprehensive Income for the Year Ended December 31, 2024 |
| ||||||||
| | | | | | | | | |
| | Dec. 31, 2024 |
| | Dec. 31, 2023 | | | | |
|
|
| | | | | | | |
Profit for the year |
| 49,619,082 | | | 26,618,249 | | | | |
| |
|
| | | | | | |
Comprehensive income items that will not be reclassified to the profit or loss: |
|
|
| | | | | | |
Change in fair value of equity instruments measured at fair value through comprehensive income | | 51,159 |
| | 259,291 | | | | |
Deferred Tax impact for investments that will not be reclassified to P&L | | (157,217) |
| | (131,008) | | | | |
Transferred to RE from financial assets at fair value through comprehensive income | | (370,224) |
| | (95,308) | | | | |
Comprehensive income items that is or may be reclassified to the profit or loss: |
|
|
| | | | | | |
Change in fair value of Financial invesments measured at fair value through comprehensive income | | 8,634,672 |
| | (7,070,544) | | | | |
Change in fair value from selling FVOCI financial instruments | | (459,337) |
| | (205,344) | | | | |
Cumulative foreign currencies translation differences | | 989,367 |
| | (32,971) | | | | |
Deferred Tax impact for investments that may be reclassified to P&L | | 887,145 |
| | 1,530,823 | | | | |
Effect of ECL in fair value of debt instruments measured at fair value through OCI | | 936,949 |
|
| 1,888,326 | | | | |
Total comprehensive income for the year | | 60,131,596 |
|
| 22,761,514 | | | | |
| |
|
| | | | | | |
As follows: |
|
|
| | | | | | |
Equity holders of the parent | | 60,071,258 |
| | 22,727,191 | | | | |
Non-controlling interest | | 60,338 |
|
| 34,323 | | | | |
Total comprehensive income for the year | | 60,131,596 |
|
| 22,761,514 | | | | |
| | | | | | | | | |
| | | | | | | | | |
| |||||
Consolidated Statement of Financial Position as at December 31, 2024 |
| | |||
| | Notes | Dec. 31, 2024 |
| Dec. 31, 2023 |
| |
|
| | |
| Assets |
|
|
| |
| Cash and balances at the central bank | 13 | 136,531,020 |
| 71,887,821 |
| Due from banks | 14 | 270,829,834 |
| 231,085,244 |
| Loans and advances to banks, net | 15 | 9,555,410 |
| 822,448 |
| Loans and advances to customers, net | 16 | 343,542,674 |
| 234,985,936 |
| Financial Assets at fair value through profit or loss | 19 | 380,769 |
| 306,375 |
| Derivative financial instruments | 17 | 819,711 |
| 1,105,148 |
| Financial Assets at fair value through OCI | 19 | 234,694,966 |
| 233,430,236 |
| Financial Assets at amortized cost | 19 | 168,118,219 |
| 38,341,019 |
| Right of use assets | 23 | 1,301,850 |
| 729,823 |
| Investments in associates | 21 | 98,193 |
| 115,979 |
| Non current assets held for sale | 42 | - |
| 161 |
| Other assets | 22 | 44,282,773 |
| 18,801,444 |
| Deferred tax assets | 10.2 | 2,685,330 |
| 1,685,230 |
| Property and equipment | 23 | 3,997,929 | | 2,739,092 |
| Total assets |
| 1,216,838,678 |
| 836,035,956 |
| Liabilities and equity |
|
|
| |
| Liabilities |
|
|
| |
| Due to banks | 24 | 2,034,885 |
| 12,458,003 |
| Due to customers | 25 | 972,595,958 |
| 677,237,479 |
| Lease liabilities | 23 | 1,425,604 |
| 674,417 |
| Derivative financial instruments | 17 | 100,571 |
| 140,934 |
| Non current liabilities held for sale | 43 | 1,397 |
| 873 |
| Issued debt instruments | 18 | 5,067,781 |
| 3,073,349 |
| Other liabilities | 27 | 27,725,569 |
| 21,937,452 |
| Current Tax liability | | 18,327,968 |
| 9,395,534 |
| Other loans | 26 | 23,962,389 |
| 12,483,907 |
| Provisions | 28 | 18,623,634 | | 11,095,996 |
| Total liabilities |
| 1,069,865,756 | | 748,497,944 |
| Equity |
|
|
| |
| Issued and paid in capital | 29 | 30,431,580 |
| 30,195,010 |
| Reserves | 30 | 62,899,966 |
| 28,362,690 |
| Reserve for employee stock ownership plan (ESOP) | 30 | 1,868,235 |
| 1,486,010 |
| Retained earnings | 30 | 51,590,097 | | 27,334,229 |
| Total equity attributable to equity holders of the parent |
| 146,789,878 | | 87,377,939 |
| Non-controlling interest | 38 | 183,044 |
| 160,073 |
| Total equity | | 146,972,922 | | 87,538,012 |
| Total liabilities and equity | | 1,216,838,678 | | 836,035,956 |
| | | | | |
| | | | | |
| The accompying notes from 1 to 44 form an integral part of these consolidated financial statements. |
| | | |
| | | | | |
| | | | | |
| Consolidated Statement of Changes in Shareholders' Equity | ||||||||||
| | | | | | ||||||
| Dec. 31, 2023 | Issued and paid in capital | Reserve for employee stock ownership plan (ESOP) | Retained earnings | Reserves | Total | Non-controlling interest | Total equity | | ||
| | | | | | | | | | ||
| Beginning balance | 29,825,134 | 1,895,435 | 15,144,290 | 19,342,866 | 66,207,725 | 580,431 | 66,788,156 | | ||
| Change in non controlling interest from acquisition of subsidiaries | - | - | - | - | - | (536,867) | (536,867) | | ||
| Net Profit for the year | - | - | 26,541,824 | - | 26,541,824 | 34,323 | 26,576,147 | | ||
| Capital increase | 369,876 | - | - | - | 369,876 | - | 369,876 | | ||
| Reserve for employee stock ownership plan (ESOP) | - | 754,817 | - | - | 754,817 | - | 754,817 | | ||
| Dividend | - | - | (2,016,159) | - | (2,016,159) | (17,108) | (2,033,267) | | ||
| Transferred to reserves | - | (1,164,242) | (12,335,726) | 9,019,824 | (4,480,144) | 99,294 | (4,380,850) | | ||
| Balance at 31 December 2023 | 30,195,010 | 1,486,010 | 27,334,229 | 28,362,690 | 87,377,939 | 160,073 | 87,538,012 |
| ||
| Dec. 31, 2024 |
| | | | | | | | ||
| Beginning balance | 30,195,010 | 1,486,010 | 27,334,229 | 28,362,690 | 87,377,939 | 160,073 | 87,538,012 |
| ||
| Net Profit for the year | - | - | 49,558,744 | - | 49,558,744 | 60,338 | 49,619,082 |
| ||
| Capital increase | 236,570 | - | - | - | 236,570 | - | 236,570 |
| ||
| Reserve for employee stock ownership plan (ESOP) | - | 1,005,350 | - | - | 1,005,350 | - | 1,005,350 |
| ||
| Dividend | - | - | (2,379,819) | - | (2,379,819) | (37,367) | (2,417,186) |
| ||
| Transferred to reserves | - | (623,125) | (22,923,057) | 34,537,276 | 10,991,094 | - | 10,991,094 |
| ||
| Balance at 31 December 2024 | 30,431,580 | 1,868,235 | 51,590,097 | 62,899,966 | 146,789,878 | 183,044 | 146,972,922 |
| ||
| | | | | | | | | | ||
| | | | | | | | | | ||
| | | | | |||||||
Consolidated Statement of Cash Flow for the Year Ended December 31, 2024 | ||||
| | | | |
| Notes | Dec. 31, 2024 |
| Dec. 31, 2023 |
|
|
| | |
| |
|
| |
Cash flow from operating activities |
|
| | |
Profit before income tax from continued operations |
| 71,498,028 |
| 38,560,655 |
(Loss) from discontinued operations |
| - |
| (42,102) |
Adjustments to reconcile profits to net cash provided by operating activities |
|
|
| |
Fixed assets depreciation | | 1,414,920 |
| 788,209 |
Impairment charge for credit losses (Loans and advances to customers) | | 4,768,107 |
| 2,311,867 |
Other provisions release/charge | | 3,363,525 |
| 2,821,141 |
Impairment release/charge for credit losses (due from banks) | | (341) |
| (47,234) |
Impairment release/charge for credit losses (financial investments) | | (243,947) |
| 2,005,448 |
Impairment release/charge for other assets | | 37,939 |
| 17,620 |
Exchange revaluation differences for financial assets at fair value through OCI and AC | | (21,026,044) |
| (5,442,433) |
Utilization of other provisions | | (9,586) |
| (5,850) |
Revaluation differences impairment charge for due from banks | | 2,008 |
| - |
Impairment of goodwill and intangible assets | | - |
| 258,118 |
Exchange revaluation differences of other provisions | | 4,173,699 |
| 1,213,126 |
Revaluation differences impairment charge for Financial Assets at Amortized cost | | 119,504 |
| 607 |
Impairment (Reversal of impairment) charges of investments in associates | | - |
| (9,000) |
Profits from selling property, plant and equipment | | (2,246) |
| (1,663) |
Profits/losses from selling financial investments at fair value through OCI | | (459,337) |
| (205,344) |
Revaluation differences impairment charge for Financial Assets at Fair value through OCI | | 1,329,905 |
| 1,903 |
Shares based payments | | 1,005,350 |
| 754,817 |
Losses (Profits) from selling investments in associates | | - |
| (7,466) |
Bank's share in the profits / losses of associates | | 17,786 |
| 55,983 |
Operating profits before changes in working capital |
| 65,989,270 |
| 43,028,402 |
| |
|
| |
Net decrease (increase) in working capital |
|
|
| |
Due from banks | | (111,192,809) |
| 18,441,280 |
Financial assets at fair value through profit or loss | | (74,394) |
| - |
Derivative financial instruments | | 490,593 |
| 755,995 |
Loans and advances to banks and customers | | (122,049,597) |
| (41,467,103) |
Other assets | | (22,078,200) |
| (3,968,123) |
Non current assets held for sale | | - |
| (161) |
Non current liabilities held for sale | | 524 |
| 873 |
Due to banks | | (10,423,118) |
| 8,961,305 |
Due to customers | | 295,358,479 |
| 145,620,929 |
Current income tax obligations paid | | (5,220,965) |
| (3,704,414) |
Other liabilities | | 5,788,117 | | 4,236,973 |
Net cash generated from operating activities |
| 96,587,900 |
| 171,905,956 |
| |
|
| |
Net cash generated from (used in) operating activities |
|
|
| |
| |
|
| |
Cash flow from investing activities |
|
|
| |
Proceeds from sale of investments in associates | | 11,956 |
| 4,510 |
Payments for purchases of property, equipment and branches construction | | (6,707,018) |
| (1,685,846) |
Proceeds from selling property and equipment | | 2,246 |
| 1,663 |
Proceeds from redemption of financial assets at amortized cost | | 2,028,180 |
| 6,125,452 |
Payments for purchases of financial assets at amortized cost | | (129,153,136) |
| (9,290,232) |
Payments for purchases of financial assets at fair value through OCI | | (113,445,585) |
| (129,073,519) |
Proceeds from selling financial assets at fair value through OCI | | 140,381,225 |
| 102,763,650 |
Payment for investment in subsidiaries | | - | | (1,142,840) |
Net cash generated from (used in) investing activities |
| (106,882,132) |
| (32,297,162) |
| | | | |
| ||||
|
|
|
| |
| |
|
| |
Cash flow from financing activities |
|
|
| |
Other loans |
| 11,478,482 |
| 4,504,932 |
Other loans - new loans obtained in the year | | 3,835,016 | | 9,604,139 |
Other loans - loans repaid in the year | | (243,015) | | (5,334,093) |
Other loans - movement in foreign exchange rate | | 7,886,481 | | 234,886 |
Dividends paid | | (2,379,819) |
| (2,016,159) |
Issued debt instruments | | 1,994,432 |
| 616,742 |
Cash payments for lease (principle and interest) | | (501,724) |
| (248,871) |
Capital increase | | 236,570 | | 369,876 |
Net cash generated from (used in) financing activities |
| 10,827,941 |
| 3,226,520 |
| |
|
| |
| |
|
| |
Net (decrease) increase in cash and cash equivalent during the year | | 533,709 |
| 142,835,314 |
Beginning balance of cash and cash equivalent | | 225,941,383 | | 83,106,069 |
Cash and cash equivalent at the end of the year |
| 226,475,092 |
| 225,941,383 |
| |
|
| |
Cash and cash equivalent at the end of the year |
|
|
| |
Cash and balances at the central bank | 13 | 136,531,020 |
| 71,887,821 |
Due from banks with maturities of 3 months or less | 14 | 203,103,430 |
| 217,156,599 |
Treasury bills and other governmental notes with maturities of three months or less | 19 | 1,618,665 |
| 1,293,148 |
Obligatory reserve balance with CBE | 13 | (114,778,023) | | (64,396,185) |
Total cash and cash equivalent | 31 | 226,475,092 |
| 225,941,383 |
| | | | |
| | | | |
| | | | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.